Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population.
暂无分享,去创建一个
J. Vandekerckhove | J. Parma | J. Dumont | G. Vassart | V. Vanvooren | J. van Sande | M. Costa | S. Noguchi | L. Duprez | S. Uchino
[1] Knut Krohn,et al. Detection of thyroid-stimulating hormone receptor and Gsα mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis , 2001, Journal of Molecular Medicine.
[2] S. Schurmans,et al. Low TSH Requirement and Goiter in Transgenic Mice Overexpressing IGF-I and IGF-I Receptor in the Thyroid Gland. , 2001, Endocrinology.
[3] T. Jørgensen,et al. Thyroid disorders in mild iodine deficiency. , 2000, Thyroid : official journal of the American Thyroid Association.
[4] T. Mori,et al. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. , 2000, European journal of endocrinology.
[5] A. Pinchera,et al. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. , 2000, The Journal of clinical endocrinology and metabolism.
[6] G. Thompson,et al. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. , 1999, The Journal of clinical endocrinology and metabolism.
[7] R. Paschke,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Clonal Origin of Toxic Thyroid Nodules with Constitutively Activating Thyrotropin Receptor Mutations* , 2022 .
[8] R. Paschke,et al. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. , 1997, The Journal of clinical endocrinology and metabolism.
[9] P. Rocmans,et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. , 1997, The Journal of clinical endocrinology and metabolism.
[10] J. Parma,et al. Constitutive activation of the TSH receptor by spontaneous mutations affecting the N‐terminal extracellular domain , 1997, FEBS letters.
[11] J. Parma,et al. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. , 1997, The Journal of clinical endocrinology and metabolism.
[12] M. Derwahl. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[13] S. Nagataki,et al. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan. , 2009, Thyroid : official journal of the American Thyroid Association.
[14] J. Fagin,et al. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. , 1996, The Journal of clinical endocrinology and metabolism.
[15] F. Cetani,et al. Oncogenic mutations in thyroid adenoma: methodological criteria. , 1996, European journal of endocrinology.
[16] M. Polak,et al. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. , 1996, The Journal of clinical endocrinology and metabolism.
[17] S. Filetti,et al. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. , 1996, The Journal of clinical endocrinology and metabolism.
[18] N. Ishikawa,et al. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. , 1995, The Journal of clinical endocrinology and metabolism.
[19] C. Als,et al. [Toxic adenomas of the thyroid gland becoming less frequent in Berne]. , 1995, Schweizerische medizinische Wochenschrift.
[20] S. Swillens,et al. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. , 1995, Molecular endocrinology.
[21] A. Porcellini,et al. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. , 1994, The Journal of clinical endocrinology and metabolism.
[22] J. Parma,et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.
[23] J. Parma,et al. The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.
[24] J. Dumont,et al. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. , 1992, Physiological reviews.
[25] E. Kawasaki,et al. Two G protein oncogenes in human endocrine tumors. , 1990, Science.
[26] J. Jauniaux,et al. The cyclic AMP-mediated stimulation of cell proliferation. , 1989, Trends in biochemical sciences.
[27] David Ninan,et al. Thyroid Disorders , 1985, Absolute Obstetric Anesthesia Review.